Marinomed Biotech AG (VIE:MARI)
Austria flag Austria · Delayed Price · Currency is EUR
19.90
-0.05 (-0.25%)
Oct 3, 2025, 5:35 PM CET

Marinomed Biotech AG Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
37274485130175
Upgrade
Market Cap Growth
325.50%-39.87%-47.78%-34.78%-25.67%19.23%
Upgrade
Enterprise Value
46476398140175
Upgrade
Last Close Price
19.9515.0029.2056.4088.00119.00
Upgrade
Forward PE
1.5911.11----
Upgrade
PS Ratio
3.765.574.727.2311.2021.57
Upgrade
PB Ratio
-6.75-1.02-3.52-20.43680.5332.71
Upgrade
P/TBV Ratio
----8983.0433.95
Upgrade
EV/Sales Ratio
4.739.726.708.3812.0621.54
Upgrade
Debt / Equity Ratio
-2.01-1.12-1.71-5.4482.542.39
Upgrade
Asset Turnover
1.030.470.540.540.520.38
Upgrade
Inventory Turnover
7.965.286.597.2610.6817.43
Upgrade
Quick Ratio
0.680.080.551.901.772.57
Upgrade
Current Ratio
0.740.100.662.402.142.75
Upgrade
Return on Equity (ROE)
-----212.34%-74.09%
Upgrade
Return on Assets (ROA)
-12.75%-42.55%-21.70%-15.14%-15.78%-20.28%
Upgrade
Return on Capital (ROIC)
-17.23%-72.25%-27.38%-19.16%-20.71%-25.90%
Upgrade
Earnings Yield
24.84%-57.79%-14.35%-7.53%-4.52%-3.43%
Upgrade
FCF Yield
--9.00%-8.34%-6.39%-4.44%-6.19%
Upgrade
Buyback Yield / Dilution
-17.17%-17.14%-1.29%-1.56%-0.31%-3.75%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.